ARMEN GARO H 4
4 · AGENUS INC · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives Stock Award
What Happened
Garo H. Armen — Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. — received 4,925 shares of Agenus common stock on June 12, 2026 as payment of salary (an award/acquisition). The shares were valued at $3.30 each (closing price) for a total reported value of $16,253. These shares were issued under the company's 2019 Equity Incentive plan and are fully vested on the date of issuance.
Key Details
- Transaction date: June 12, 2026; filing date: June 16, 2026 (appears to be filed after the typical 2-business-day Form 4 window).
- Shares received: 4,925 at $3.30 per share; total value reported: $16,253. ($3.30 is the June 12, 2026 closing price.)
- Ownership after transaction: The Form 4 does not state a consolidated total of shares beneficially owned after this issuance. The filing notes these shares are held in Dr. Armen's IRA accounts.
- Notable footnotes: (1) Salary paid in stock with Compensation Committee approval; (2) shares fully vested at issuance; (3) shares held in IRA; (4) Dr. Armen has additional related holdings — 23,950 shares held by a 2020 GRAT for which he is trustee and investment authority, and Pixie Partners holds 5,000 shares in which he has a partial pecuniary interest (he disclaims beneficial ownership to the extent of that partial interest).
Context
This was not an open-market purchase or sale but a conversion of salary into company stock — a routine form of compensation rather than an independent buy/sell decision. Because the shares are fully vested on issuance, there are no additional vesting conditions tied to this grant. The filing date suggests the Form 4 may have been submitted after the standard 2-business-day reporting window.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-12$3.30/sh+4,925$16,253→ 360,892 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F2]$3.30 is the closing price of our Common Stock on June 12th, 2026, the last trading day for the payroll date for the pay period ending June 12th, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 12th, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.